Merck Singulair Presents Managed Care Test: Covering Asthma, Not Allergies

Merck's Singulair approval in allergic rhinitis presents a challenge for managed care to differentiate between the drug's existing asthma indication and its use in allergies when making coverage decisions

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet